Picrasidine I

• Description :

  Picrasidine I has antiosteoclastogenic effect by inhibiting inflammation induced activation of MAPKs, ROS generation followed by suppressing the gene expression of c-Fos and NFATc1 in osteoclast precursors.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  240.3

• Molecular Formula :

  C14H12N2O2

• Notes :

  Research use only, not for human use.

• Receptor :

  ——

• CAS Number :

  100234-59-1